Alamar Biosciences (ALMR) stock
ALMR's Quality Score rose 1 point on Mon, Oct 5, to 5. Buying volume reached a 20-day high (2 chart checks started).
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Why ALMR scores 5
Below AverageTrending up, 6 of 14 checks firingWhat the Quality Score means
- +6Chart checks 6 of 14 firing right now, one point each
- −1Volatility moves 6.2% a day with no profit or positive free cash flow over four quarters on file
What's next
Wed Oct 14: IPO lockup endsAt the open. The 180-day lockup ends.
Expected to report Thu Nov 5, before the open
After its last 2 reports it closed +16.0% on average, higher 2 of 2 times.
1 more date ahead for Pro members: the IPO anniversary
What would turn ALMR's score around: 3 things, for Pro members
Here is what Pro members see.
- Prices refresh every 2.5 seconds during market hours.
- Optional alerts by push, email, or the bell.
- Add it to your Home Screen and it opens like an app.
ALMR has 6 of 14 checks firing
One per group is shown here.
Also on the chart
- RSI 1467.7
- MACD (12, 26, 9)Above signal
- 50-day average$31.00
- ADX 1432.3
- Support$27.25
- Resistance$38.54
- Volume1.1x
How ALMR ranks in Life Science Tools
ALMR is #13 of 16 by Quality Score among Laboratory Analytical Instruments. The top three are shown with their scores, and more by name.
RVTY9/1419
A7/1417
MASS8/1415
AVTROpen for its score
BIOOpen for its score
WATOpen for its score
ALMR6/145
When does ALMR report earnings, and what happens after?
Expected to report Thu Nov 5, before the open (in 30 days). Not yet confirmed by the company.
| Reported | When | Gap | Reaction | 5 sessions |
|---|---|---|---|---|
| Aug 10, 2026After close | After close | +3.6% | +30.6% | +14.8% |
| May 8, 2026Before open | Before open | -2.3% | +1.3% | -4.9% |
About Alamar Biosciences
Alamar Biosciences Inc is a proteomics company engaged in protein detection and analysis. The company has developed its own NULISA (NUcleic Acid Linked Immuno-Sandwich Assay) technology as the foundation of its Precision Proteomics platform enabling the detection and quantification of protein biomarkers in a single sample with ultra-high sensitivity and high specificity, even from very small volumes of biofluid. The company operates in single segment and focuses on developing a good sensitive proteomic liquid biopsy platform and sells instruments, consumables, and services based on this platform to enable early detection of diseases. The products of the company includes NULISAseq Panels, NULISAqpcr Assays, and others.
Pro members see every line of every stock's score.
- Real-time prices, no delay
- Every line of ALMR's score, with the points and the reason
- All 14 checks on ALMR and on all 3,243 stocks
- Every stock ranked, with the chart
- Every filing, and optional alerts on ALMR
Straight Answers
Are the prices delayed?
Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.
Where does the data come from?
Daily bars, quotes, reference data, headlines, and short interest come from Massive, formerly Polygon, a licensed market data vendor. The age of the quotes is shown at the top of every page. Insider trades, notable holders and profits come straight from the SEC. That means Form 4 filings, 13F filings and XBRL financial data on EDGAR. Government filings come from the public STOCK Act and Office of Government Ethics disclosures. The market-wide headlines on the market line also come from the public headline feeds CNBC, MarketWatch and Yahoo Finance publish, shown as the headline, the source and a link to the article. Splits, dividends, and the financial statements on each ticker page come from the vendor's reference data. The 8-K filings on EDGAR are read for the items that move a price. Five years of history is loaded for every stock. So the 200-day and 52-week checks rest on real history. Options flow is not part of the product.
Do I need an account?
Not to start. Tap any green button and you're in, free, with no email and no password. To keep going, create a free account with Google, Apple, or your email. There is no password to make up.
Is this investment advice?
No. It is a screening tool that scores stocks on the chart, the company's own results, and the news and filings. It does not know your situation and it is not a recommendation to buy or sell anything. Please do your own research.